Escitalopram Oxalate

Escitalopram Oxalate
Details:
CAS No. 219861-08-2
Molecular Formula: C22H23F2NO8
Molecular Weight: 414.43 g/mol
Send Inquiry
Chat Now
Download
Description
Technical Parameters

Escitalopram Oxalate is the oxalate salt form of escitalopram, a selective serotonin reuptake inhibitor utilized primarily in the treatment of major depressive disorder and generalized anxiety disorder. Produced via advanced asymmetric synthesis and stereoselective crystallization techniques, this active pharmaceutical ingredient exhibits high enantiomeric purity. It functions by inhibiting the neuronal reuptake of serotonin, thereby enhancing serotonergic neurotransmission in the central nervous system.

 

Product Information

 

Parameter

Specification Details

International Nonproprietary Name

Escitalopram Oxalate

Chemical Name

(1S)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile oxalate

Therapeutic Category

Antidepressant / Selective Serotonin Reuptake Inhibitor

Grade

Pharmaceutical Commercial Grade

Physical Description

White or almost white crystalline powder

Solubility Profile

Sparingly soluble in water; freely soluble in methanol; slightly soluble in ethanol

 

Quality & Specification

 

Test Parameter

Acceptance Criteria

Analytical Method

Assay (Dried Basis)

98.0% - 102.0%

High-Performance Liquid Chromatography

Appearance of Solution

Clear and colorless

European Pharmacopoeia / United States Pharmacopeia

Chiral Purity (R-enantiomer)

≤ 0.1 %

Chiral Liquid Chromatography

Individual Specified Impurity

≤ 0.10 %

Liquid Chromatography

Total Impurities

≤ 0.5 %

Liquid Chromatography

Loss on Drying

≤ 0.5 %

Gravimetric Analysis

Residue on Ignition

≤ 0.1 %

Sulfated Ash Test

Heavy Metals

≤ 10 ppm

Inductively Coupled Plasma Mass Spectrometry

 

Manufacturing & Supply

 

Synthesis Route: Asymmetric reduction followed by fractional crystallization to isolate the active S-enantiomer configuration.

 

Cleanroom Classification: Synthesis, isolation, and micronization executed within ISO Class 8 cleanroom environments.

 

Containment & Handling: Closed-system reactors equipped with automated nitrogen purging to prevent moisture absorption and cross-contamination.

 

Batch Scale & Capacity: Commercial-scale production capabilities ranging from multi-hundred-kilogram to metric-ton annual output.

 

Supply Stability: Maintained safety stock of key starting materials and validated dual-sourcing channels for critical raw components.

 

Documentation

 

Regulatory Dossiers: Drug Master File available for reference and active European Pharmacopoeia compliance data.

 

Certificates of Analysis: Issued for every individual production batch, detailing full analytical results against pharmacopoeial monographs.

 

Compliance Certificates: Good Manufacturing Practice certificates and Written Confirmation for active substances imported into regulated markets.

 

Supporting Data: Full impurity profiling reports, residual solvent validation data, stability study summaries, and TSE/BSE-free statements.

 

Packaging

 

Primary Packaging

Double-layer food-grade low-density polyethylene bags, heat-sealed to ensure absolute moisture and light protection.

Secondary Packaging

Rigid fiber drums or rigid high-density polyethylene drums lined with tamper-evident seals.

Standard Batch Packaging Size

25 kg net weight per drum.

Storage Conditions

Store below 25°C in a dry, well-ventilated area protected from direct sunlight and moisture.

 

Pharmaceutical Application

 

Major Depressive Disorder: Formulated into oral tablets and liquid solutions to manage acute and maintenance phases of clinical depression. Restores neurochemical balance by sustaining extracellular serotonin levels in synaptic clefts.

 

Generalized Anxiety Disorder: Utilized in solid oral dosage manufacturing for chronic anxiety management. Regulates emotional and somatic symptoms through continuous central nervous system modulation.

 

Social Anxiety Disorder: Applied in specialized tablet formulations targeting chronic social fear and avoidance behaviors. Supports long-term psychiatric rehabilitation protocols.

 

Panic Disorder: Integrated into precise dose-strength tablets designed to reduce the frequency and intensity of unexpected panic attacks. Stabilizes autonomic nervous system responses over therapeutic treatment cycles.

 

FAQ

 

Q: What is the standard minimum order quantity for commercial orders?

A: The standard minimum order quantity for commercial batches is 25 kg, with pilot-scale sample quantities available upon request for technical evaluation.

Q: Is a Drug Master File available for regulatory submissions?

A: Yes, a comprehensive Drug Master File is maintained and available for submission to regulatory authorities to support customer regulatory filings.

Q: How is chiral purity verified during production?

A: Chiral purity is monitored using validated high-performance liquid chromatography methods with chiral stationary phases to ensure the R-enantiomer remains below established pharmacopoeial thresholds.

Q: What are the recommended storage and handling conditions?

A: The material should be stored in original sealed containers below 25°C, protected from humidity, strong light, and atmospheric oxidation.

Q: Are reference analytical standards provided with the shipment?

A: Working analytical standards and comprehensive impurity reference markers can be supplied alongside commercial batches upon technical request.

 

Hot Tags: escitalopram oxalate, China escitalopram oxalate manufacturers, suppliers, factory

Send Inquiry